The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity

Area of Science:

• Molecular biology
• Immunology
• Virology

Background:

• Tumor necrosis factor receptor-1-associated death domain (TRADD) protein mediates apoptosis and NF-kappaB activation via TNF-receptor 1 (TNFR1).
• Epstein-Barr virus's latent membrane protein 1 (LMP1) oncoprotein recruits TRADD, but its signaling role remains unclear.
• Understanding TRADD's function in LMP1 signaling is vital for comprehending viral-induced cellular changes.

Purpose of the Study:

• To investigate the role of TRADD in LMP1 signal transduction in human B lymphocytes.
• To elucidate the molecular mechanisms underlying TRADD's differential signaling in response to LMP1 versus TNFR1.
• To identify the specific domains of LMP1 responsible for TRADD interaction and signaling outcomes.

Main Methods:

• Generation of TRADD-deficient human B lymphocytes.
• Analysis of NF-kappaB activation and apoptosis induction.
• Site-directed mutagenesis of LMP1 and TNFR1.
• Biochemical assays to study protein-protein interactions and signaling pathways.

Main Results:

• TRADD is essential for LMP1-mediated recruitment and activation of I-kappaB kinase beta (IKKbeta).
• LMP1-induced TRADD signaling activates NF-kappaB but does not induce apoptosis, contrasting with TNFR1 signaling.
• The C-terminal 16 amino acids of LMP1 form a unique TRADD-binding domain.
• Replacing TNFR1's death domain with LMP1's TRADD-binding domain creates a nonapoptotic, NF-kappaB-activating receptor.

Conclusions:

• TRADD is a critical mediator of LMP1 signal transduction, distinct from its role in TNFR1 signaling.
• The unique TRADD-binding domain of LMP1 dictates nonapoptotic NF-kappaB activation, contributing to the viral transforming phenotype.
• LMP1 interaction with TRADD masks the pro-apoptotic function of TRADD, highlighting viral manipulation of host cell pathways.